DE60132008D1 - Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis - Google Patents
Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasisInfo
- Publication number
- DE60132008D1 DE60132008D1 DE60132008T DE60132008T DE60132008D1 DE 60132008 D1 DE60132008 D1 DE 60132008D1 DE 60132008 T DE60132008 T DE 60132008T DE 60132008 T DE60132008 T DE 60132008T DE 60132008 D1 DE60132008 D1 DE 60132008D1
- Authority
- DE
- Germany
- Prior art keywords
- psoriasis
- treatment
- eccements
- cethylmyristate
- cetylpalmitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 title abstract 2
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 229940074979 cetyl palmitate Drugs 0.000 title abstract 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 title abstract 2
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 abstract 2
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ50452500A NZ504525A (en) | 2000-05-12 | 2000-05-12 | Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis |
| NZ50452500 | 2000-05-12 | ||
| NZ50722800 | 2000-09-28 | ||
| NZ50722800 | 2000-09-28 | ||
| PCT/NZ2001/000085 WO2001085163A1 (en) | 2000-05-12 | 2001-05-11 | Treating eczema and/or psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60132008D1 true DE60132008D1 (de) | 2008-01-31 |
| DE60132008T2 DE60132008T2 (de) | 2008-12-11 |
Family
ID=26652173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60132008T Expired - Lifetime DE60132008T2 (de) | 2000-05-12 | 2001-05-11 | Cetylmyristat und cetylpalmitat zur behandlung von ekzemen und/oder psoriasis |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1335719B1 (de) |
| AT (1) | ATE381327T1 (de) |
| AU (2) | AU2001260833B2 (de) |
| CA (1) | CA2408541C (de) |
| CY (1) | CY1107242T1 (de) |
| DE (1) | DE60132008T2 (de) |
| ES (1) | ES2298237T3 (de) |
| WO (1) | WO2001085163A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
| US6696491B2 (en) * | 2000-05-12 | 2004-02-24 | Meracol Corporation Limited | Treating irritable bowel syndrome or disease |
| NZ533370A (en) | 2004-06-03 | 2006-11-30 | Meracol Corp Ltd | Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis |
| EP2149375A1 (de) | 2008-07-28 | 2010-02-03 | Despharma Kft. | Zusammensetzungen zur Behandlung von dermatologischen Krankheiten und Verwendungen dafür |
| EP2543364A1 (de) | 2010-10-14 | 2013-01-09 | Deva Holding Anonim Sirketi | Formulierungen von Cetylmyristat und/oder Cetylpalmitat |
| EP2441441A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Siebverfahren für Cetylmyristat und/oder Cetylpalmitat |
| EP2441446A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Verwendung von Supersprengmittel in Cetylmyristat und/oder Cetylpalmitatformulierungen |
| EP2441445A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Cetylmyristat- und/oder Cetylpalmitatteilchenbeschichtung |
| EP2471528A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Eine Herstellungsmethode für Cetyl Myristat und/oder Cetyl Palmitat Suspensionen |
| EP2471384A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensions Formulierungen für Cetyl myristat und/oder Cetyl palmitat |
| EP2471385A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| EP2471514A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Kontrollierter Feuchtigkeitsgehalt von Cetyl Myristat und/oder Cetyl Palmitat Granulaten oder Formulierungen |
| EP2471386A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| EP2471387A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| ES2538079T3 (es) | 2011-05-23 | 2015-06-17 | Deva Holding Anonim Sirketi | Distribución de tamaño de partícula del miristato de cetilo y/o palmitato de cetilo |
| EP2526931B1 (de) | 2011-05-23 | 2014-12-17 | Deva Holding Anonim Sirketi | Nasse Granulationsmethoden für Cetylmyristat und/oder Cetylpalmitat |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8600161A (nl) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten. |
| DE4308282C2 (de) * | 1993-03-16 | 1994-12-22 | Beiersdorf Ag | Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices |
| US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| DE19819273A1 (de) * | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung |
| EP1080226A4 (de) * | 1998-05-21 | 2004-04-21 | Isis Pharmaceuticals Inc | Zusammensetzungen und methoden zur topischen verabreichung von oligonukleotiden |
| GB9810949D0 (en) * | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
| US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
| WO2000067728A2 (de) * | 1999-05-07 | 2000-11-16 | Pharmasol Gmbh | Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung |
| US6696491B2 (en) * | 2000-05-12 | 2004-02-24 | Meracol Corporation Limited | Treating irritable bowel syndrome or disease |
-
2001
- 2001-05-11 WO PCT/NZ2001/000085 patent/WO2001085163A1/en active IP Right Grant
- 2001-05-11 CA CA002408541A patent/CA2408541C/en not_active Expired - Fee Related
- 2001-05-11 DE DE60132008T patent/DE60132008T2/de not_active Expired - Lifetime
- 2001-05-11 EP EP01934672A patent/EP1335719B1/de not_active Expired - Lifetime
- 2001-05-11 AT AT01934672T patent/ATE381327T1/de active
- 2001-05-11 AU AU2001260833A patent/AU2001260833B2/en not_active Ceased
- 2001-05-11 AU AU6083301A patent/AU6083301A/xx active Pending
- 2001-05-11 ES ES01934672T patent/ES2298237T3/es not_active Expired - Lifetime
-
2008
- 2008-03-17 CY CY20081100293T patent/CY1107242T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2408541A1 (en) | 2001-11-15 |
| ATE381327T1 (de) | 2008-01-15 |
| ES2298237T3 (es) | 2008-05-16 |
| AU2001260833B2 (en) | 2005-09-29 |
| AU6083301A (en) | 2001-11-20 |
| CY1107242T1 (el) | 2012-11-21 |
| EP1335719A1 (de) | 2003-08-20 |
| WO2001085163A1 (en) | 2001-11-15 |
| DE60132008T2 (de) | 2008-12-11 |
| EP1335719B1 (de) | 2007-12-19 |
| CA2408541C (en) | 2009-07-28 |
| EP1335719A4 (de) | 2004-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107242T1 (el) | Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης | |
| TR199903034T2 (xx) | Piperazin t�revleri ve anti-enflamatuvar ajan olarak kullan�mlar�. | |
| ATE196844T1 (de) | Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten | |
| BR9707233A (pt) | Fenantridinas | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
| DE69408309D1 (de) | Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen | |
| DE60132444D1 (de) | Behandlung von reizkolon-syndrom oder -krankheit | |
| DK0889886T5 (da) | Hidtil ukendte, i 6-stilling substituerede phenanthridiner | |
| DK0839143T3 (da) | Tetralinforbindelser med MDR-aktivitet | |
| CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
| PT705100E (pt) | Guanidinas substituidas terapeuticas | |
| DE69710065D1 (de) | Androsten-derivate | |
| DE69322912D1 (de) | Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E | |
| DE69825279D1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
| ATE199641T1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| LV11593A (lv) | Dimetikona pielietojums aizcietejumu arstesana | |
| DE69230644D1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
| SE8403659L (sv) | Synergistiska farmaceutiska kompositioner | |
| BR0015121A (pt) | Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação | |
| FI972637A0 (fi) | K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon | |
| TR199800705T2 (de) | ||
| TR200000916T2 (tr) | İkameli piperidin türevleri. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |